📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes. (2021)

First Author: Roehmel JF

Attributed to: Development of a stepwise screening approach to assess the intrinsic immunogenicity of drugs and chemicals funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2020.05.041

PubMed Identifier: 32526307

Publication URI: http://europepmc.org/abstract/MED/32526307

Type: Journal Article/Review

Volume: 147

Parent Publication: The Journal of allergy and clinical immunology

Issue: 2

ISSN: 0091-6749